Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


VIVUS, Inc. 

1172 Castro Street

Mountain View  California  94040  U.S.A.
Phone: 650-934-5200 Fax: 650-934-5389



 Company News
VIVUS Announces Date Of Third Quarter 2014 Update And Financial Results Conference Call 10/30/2014 8:31:12 AM
Auxilium Pharmaceuticals (AUXL), VIVUS, Inc. (VVUS)'s Faster-Acting Erectile Dysfunction Drug Wins FDA Approval 9/18/2014 6:15:22 AM
VIVUS, Inc. (VVUS) Snags A Group Of Topiramate Patents From Johnson & Johnson (JNJ) 8/26/2014 5:52:30 AM
Top VIVUS, Inc. (VVUS) Shareholder Plans To Buy Company In $640 Million Deal 5/29/2014 7:32:33 AM
VIVUS, Inc. (VVUS)'s Diet Pill Faces Generic Threat From Actavis (ACT) 5/12/2014 7:18:23 AM
VIVUS, Inc. (VVUS) Announces Date Of First Quarter 2014 Update And Financial Results Conference Call 4/29/2014 9:15:16 AM
VIVUS, Inc. (VVUS) Reports Fourth Quarter And Year-End 2013 Financial Results 2/25/2014 9:21:04 AM
VIVUS, Inc. (VVUS) Announces Date Of Fourth Quarter And Year End 2013 Financial Results And Conference Call 2/19/2014 9:01:23 AM
VIVUS, Inc. (VVUS) Pays CEO Seth Fischer $104,000 Bonus 1/31/2014 8:00:54 AM
VIVUS, Inc. (VVUS) And Auxilium Pharmaceuticals (AUXL) Announce FDA Acceptance Of Supplemental Filing Seeking An Update Of Prescribing Information For STENDRA (Avanafil) 1/23/2014 10:43:47 AM